Zobrazeno 1 - 10
of 48
pro vyhledávání: '"G, Priol"'
Publikováno v:
Annals of the Rheumatic Diseases. 66:81-85
Background: Vertebral fractures are underdiagnosed, although the resulting mortality and morbidity in postmenopausal women with osteoporosis is now recognised. In a population of postmenopausal women with osteoporosis and back pain, symptoms may be r
Autor:
Yvon Lebranchu, G Priol, C Le Pen, H Lilliu, A. Al Najjar, O Reigneau, Mathias Büchler, C Brun-Strang
Publikováno v:
Clinical Transplantation. 18:247-253
Purpose: Based on the data of clinical trial CHI-F-02 comparing the efficacy and safety of basiliximab (Simulect®) vs. anti-thymocyte globulin (Thymoglobulin®) in renal transplant induction, we carried out an economic evaluation. Method: This pharm
Publikováno v:
The European Journal of Health Economics. 4:30-36
The criteria for the registration of new drugs may differ from the criteria for drug reimbursement. In 2000 the French government entrusted the French Medicines Agency with determining the “medical service rendered” (MSR) for each reimbursable dr
Publikováno v:
European Respiratory Journal. 20:899-906
In a previous panel study in Paris, France, detrimental effects of moderately high levels of winter air pollution on the symptoms and lung function of asthmatic children were demonstrated. A new study was conducted, with the aim of assessing the shor
Publikováno v:
Numerical Models in Geomechanics: Proceedings of the Tenth International Symposium on Numerical Models in Geomechanics (NUMOG X), Rhodes, Greece, 25-27 April 2007
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ef0efd8a857e8088d6f152e660027b
https://doi.org/10.1201/noe0415440271.ch81
https://doi.org/10.1201/noe0415440271.ch81
Publikováno v:
Numerical Models in Geomechanics: Proceedings of the Tenth International Symposium on Numerical Models in Geomechanics (NUMOG X), Rhodes, Greece, 25-27 April 2007
Scopus-Elsevier
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5d58aab5222082a57cdf0f722442f2
https://doi.org/10.1201/noe0415440271.ch75
https://doi.org/10.1201/noe0415440271.ch75
Publikováno v:
Value in Health. 8(6)
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care. 4(1)
The criteria for the registration of new drugs may differ from the criteria for drug reimbursement. In 2000 the French government entrusted the French Medicines Agency with determining the "medical service rendered" (MSR) for each reimbursable drug.
Autor:
G Giret d'Orsay, M Riviere, Marie Ligier Ligier, C Le Pen, F Maurel, G Priol, Hervé Bard, Bernard Mazières, AM Bacri
Publikováno v:
Value in Health. 7(6)